224 related articles for article (PubMed ID: 33882617)
1. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
Cheng Q; Bao L; Li M; Chang K; Yi X
J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo.
Zhou B; Xia M; Wang B; Thapa N; Gan L; Sun C; Guo E; Huang J; Lu Y; Cai H
J Ovarian Res; 2019 Nov; 12(1):107. PubMed ID: 31703731
[TBL] [Abstract][Full Text] [Related]
3. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
[TBL] [Abstract][Full Text] [Related]
4. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
5. Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.
Li Y; Yan H; Xu X; Liu H; Wu C; Zhao L
Oncol Lett; 2020 Jan; 19(1):323-333. PubMed ID: 31897145
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS.
Wang L; Wang C; Li X; Tao Z; Zhu W; Su Y; Choi WS
Cell Mol Biol Lett; 2023 May; 28(1):36. PubMed ID: 37131152
[TBL] [Abstract][Full Text] [Related]
7. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.
Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F
Front Oncol; 2022; 12():868351. PubMed ID: 35433479
[TBL] [Abstract][Full Text] [Related]
8. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer.
Gai C; Yu M; Li Z; Wang Y; Ding D; Zheng J; Lv S; Zhang W; Li W
J Cell Physiol; 2020 Apr; 235(4):3329-3339. PubMed ID: 31541463
[TBL] [Abstract][Full Text] [Related]
9. Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis.
Li Y; Zeng X; Lu D; Yin M; Shan M; Gao Y
Hum Reprod; 2021 Mar; 36(4):951-964. PubMed ID: 33378529
[TBL] [Abstract][Full Text] [Related]
10. Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells.
Hao S; Yu J; He W; Huang Q; Zhao Y; Liang B; Zhang S; Wen Z; Dong S; Rao J; Liao W; Shi M
Neoplasia; 2017 Dec; 19(12):1022-1032. PubMed ID: 29144989
[TBL] [Abstract][Full Text] [Related]
11. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.
Liu N; Lin X; Huang C
Br J Cancer; 2020 Jan; 122(2):279-292. PubMed ID: 31819185
[TBL] [Abstract][Full Text] [Related]
12. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
13. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
Shibata Y; Yasui H; Higashikawa K; Miyamoto N; Kuge Y
PLoS One; 2019; 14(12):e0225931. PubMed ID: 31800616
[TBL] [Abstract][Full Text] [Related]
14. MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells.
Gai C; Liu C; Wu X; Yu M; Zheng J; Zhang W; Lv S; Li W
Cell Death Dis; 2020 Sep; 11(9):751. PubMed ID: 32929075
[TBL] [Abstract][Full Text] [Related]
15. CPEB1 enhances erastin-induced ferroptosis in gastric cancer cells by suppressing twist1 expression.
Wang J; Wang T; Zhang Y; Liu J; Song J; Han Y; Wang L; Yang S; Zhu L; Geng R; Li W; Yu X
IUBMB Life; 2021 Sep; 73(9):1180-1190. PubMed ID: 34184391
[TBL] [Abstract][Full Text] [Related]
16. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
Wu X; Liu C; Li Z; Gai C; Ding D; Chen W; Hao F; Li W
Mol Cell Biochem; 2020 Oct; 473(1-2):217-228. PubMed ID: 32642794
[TBL] [Abstract][Full Text] [Related]
17. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis.
Liu M; Fan Y; Li D; Han B; Meng Y; Chen F; Liu T; Song Z; Han Y; Huang L; Chang Y; Cao P; Nakai A; Tan K
Mol Oncol; 2021 Aug; 15(8):2084-2105. PubMed ID: 33675143
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells.
Bai T; Liang R; Zhu R; Wang W; Zhou L; Sun Y
J Cell Physiol; 2020 Jul; 235(7-8):5637-5648. PubMed ID: 31960438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
